Yosores, Rejelyn E.
HRN: 26-79-74 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/19/2025
CEFUROXIME 500MG (TAB)
03/19/2025
03/26/2025
ORAL
1 Tablet
BID
Thickly MSAF
Waiting Final Action
Indication: Prophylaxis Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes